Divi's Laboratories balance sheet

·Pharma & HealthChart ›
As of Mar 2026
Total assets
₹20,033cr+18.3% on Mar 2025
Shareholders' equity
₹16,761cr+12.0% on Mar 2025
Total debt
₹0.0cr−100.0% on Mar 2025
Cash and investments
₹128cr−69.2% on Mar 2025
₹ crore except per share
Tap a line for its trendFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
Non-current assets
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
6,5155,4374,7334,714
2,1131,022778212
13.04.06.08.4
69.065.082.077.1
67.062.056.051.1
136127138128
14.011.010.014.2
14625013050.2
8,9376,8515,7955,127
Current assets
3,9543,2363,1843,000
2,9842,7312,1561,793
128415363170
3,2863,3003,6174,043
8.016.07.06.1
6,4066,4626,1436,012
736383348300
11,09610,0819,6759,312
20,03316,93215,47014,439
Equity
53.053.053.053.1
16,70814,91613,51812,714
16,76114,96913,57112,767
—873——
16,76114,96913,57112,767
Liabilities
4612.02.02.8
4612.02.02.8
81.00.037.030.6
469509582537
218———
1,229511621571
0.02.00.00.0
1,211910824763
46213410143.9
1,6731,046925806
60.054.07.04.9
12.00.043.02.2
298352303288
2,0431,4521,2781,101
3,2721,9631,8991,672
20,03316,93215,47014,439
Trade payables — MSME split
62.037.0——
1,149873——
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

DIVISLAB₹9,558.50

Divi's Laboratories Ltd.

· Pharma & Health
₹ CrorePeersLAURUSLABSCOHANCEGLANDTORNTPHARMZYDUSLIFEMAXHEALTHDRREDDYCIPLAMcap ₹2.53L Cr
View
In ₹ Crore except Per Share
As of
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Non-current Assets
+ Property, Plant & Equipment4,714.24,733.05,437.06,515.06,515.0
+ Capital Work-in-Progress211.9778.01,022.02,113.02,113.0
+ Other Intangibles8.46.04.013.013.0
+ Non-current Investments77.182.065.069.069.0
+ Other Non-current Financial Assets51.156.062.067.067.0
Non-current Financial Assets128.1138.0127.0136.0136.0
+ Deferred Tax Assets14.210.011.014.014.0
+ Other Non-current Assets50.2130.0250.0146.0146.0
Total Non-current Assets5,127.05,795.06,851.08,937.08,937.0
Current Assets
+ Inventories3,000.43,184.03,236.03,954.03,954.0
+ Trade Receivables1,792.52,156.02,731.02,984.02,984.0
+ Cash & Cash Equivalents169.7363.0415.0128.0128.0
+ Other Bank Balances4,043.43,617.03,300.03,286.03,286.0
+ Other Current Financial Assets6.17.016.08.08.0
Current Financial Assets6,011.76,143.06,462.06,406.06,406.0
+ Other Current Assets299.6348.0383.0736.0736.0
Total Current Assets9,311.79,675.010,081.011,096.011,096.0
Total Assets14,438.815,470.016,932.020,033.020,033.0
Equity
+ Equity Share Capital53.153.053.053.053.0
+ Other Equity / Reserves12,714.013,518.014,916.016,708.016,708.0
Equity — Owners of Parent12,767.113,571.014,969.016,761.016,761.0
+ Minority Interest——873.0——
Total Equity12,767.113,571.014,969.016,761.016,761.0
Liabilities
+ Other Non-current Financial Liab2.82.02.0461.0461.0
Non-current Financial Liabilities2.82.02.0461.0461.0
+ Provisions — Non-current30.637.00.081.081.0
+ Deferred Tax Liabilities537.2582.0509.0469.0469.0
+ Other Non-current Liabilities———218.0218.0
Non-current Liabilities570.6621.0511.01,229.01,229.0
+ Borrowings — Current0.00.02.00.00.0
+ Trade Payables762.5824.0910.01,211.01,211.0
+ Other Current Financial Liab43.9101.0134.0462.0462.0
Current Financial Liabilities806.4925.01,046.01,673.01,673.0
+ Provisions — Current4.97.054.060.060.0
+ Current Tax Liabilities2.243.00.012.012.0
+ Other Current Liabilities287.6303.0352.0298.0298.0
Current Liabilities1,101.11,278.01,452.02,043.02,043.0
Total Liabilities1,671.71,899.01,963.03,272.03,272.0
Total Equity & Liabilities14,438.815,470.016,932.020,033.020,033.0
Trade Payables — MSME split
+ Dues to Micro & Small — Current——37.062.062.0
+ Dues to Other Creditors — Current——873.01,149.01,149.0
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.